Supplementary Figure 14 from Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma
Year: 2026
Type: supplementary-materials
Abstract: Fig. S14. Treatment with CAR-12.DR18 T cells does not lead to permanent brain tissue damage.
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7172381693
